Unveiling Immunology and Microbiology Innovations to Fight Contagious and Communicable Diseases
Los Angeles, CA (PRWEB) February 06, 2015 -- Immunology and Microbiology conferences cover a wide range of aspects within this field including, microorganisms, human defense mechanisms that deal with research on Vaccines and Vaccination, Infectious diseases, Parasitology, Retroviruses, HIV/AIDS, and Influenza.
Immunology and Microbiology conferences are well structured scientific events consisting workshops, symposia and B2B meetings with cutting edge research presentations from various Academicians, Researchers and Industry key leaders.
Immunology and Microbiology conferences attain greater significance in the wake of frequent outbreak of communicable diseases worldwide, causing serious health concerns. These conferences provide a meaningful platform to the researchers to unlock the mysteries so that the humanity could eradicate the pathogens, strengthening the immune system. Global Bio Pharmaceuticals & Researchers are keen in sharing novel therapeutic and prophylactic approaches developed to fight infectious diseases with an increased R&D expenditure.
The global market of Immunology is expected to reach over $138 billion worldwide by 2016 with a compound annual growth rate (CAGR) of 2.3 percent annually. This is accounting for nearly 20 percent of the global pharmaceutical market by 2016. The inextricable linkage of Immunology with microbiology has accounted for the rise in the microbiology market during 2014 where the global microbiology market reached $6,727.29 million mark. It is expected to grow at a CAGR of 13.03% from 2014 to 2019.
OMICS Group is organizing more than 300 scientific events every year across USA, Europe, Middle East and Asia. These conferences create a venue to connect and share recent research, knowledge and development in various fields, involving established researchers, scientists, entrepreneurs and students. B2B and Scientific meetings organized by us are excellent platform for networking and business development.
OMICS International has an enhanced and highlighted feature of scientific partnerships and alliances with development agencies, Institutes, leading research organizations, non-government organizations, and other entities to promote the development-oriented research all around the globe. It has collaborated with more than 1000 Scientific Associations and institutions worldwide to promote information on health care through its 500 Peer reviewed, Open Access Journals. These journals are enjoying the support of over 5 million readers. A team of 30.000 eminent scholars are providing editorial support, assisting them in publishing standard research articles and reviews.
Issac Samuel, OMICS International, http://omicsonline.org, +1 (888) 843-8169, [email protected]
Share this article